Physician profile
Rahul Kumar
NPI 1912074964
$8,538.31
in general payments reported to CMS, 2019-2025
27 companies · $2,930 in 2025
The $2,930 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,013 · 2020: $1,294 · 2021: $1,233 · 2022: $843 · 2023: $850 · 2024: $374 · 2025: $2,930.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,345 · Travel and Lodging: $1,709 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,345.39 |
| Travel and Lodging | $1,709.35 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,181.65 | 2023-2025 | Aveir, Assurity, Merlin@Home |
| Medtronic, INC. | $1,551.63 | 2021-2025 | Claria Mri Quad Crt-D Surescan, Micra, Cobalt Dr Mri Surescan |
| Biosense Webster, INC. | $1,123.42 | 2019-2023 | Carto 3, Soundstar, Smartablatetm System Rf Generator |
| Medtronic Vascular, INC. | $832.49 | 2019-2020 | |
| Boston Scientific Corporation | $756.91 | 2019-2025 | Accolade Sr, General - Tachy, Ingevity+ |
| Biotronik INC. | $687.42 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $199.37 | 2020-2025 | |
| E.R. Squibb & Sons, L.L.C. | $153.23 | 2019-2024 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $142.56 | 2019-2025 | Jardiance |
| United Therapeutics Corporation | $127.00 | 2025 | Tyvaso |
| Astrazeneca Pharmaceuticals LP | $114.96 | 2023 | Brilinta, Farxiga |
| Atricure, INC. | $98.38 | 2020-2023 | |
| Merck Sharp & Dohme LLC | $74.23 | 2021-2025 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $68.43 | 2020-2021 | |
| Bardy Diagnostics, INC. | $67.00 | 2020-2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $53.09 | 2025 | |
| Baxter Healthcare | $51.72 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Amgen INC. | $47.66 | 2020-2025 | Repatha |
| Pfizer INC. | $31.06 | 2021-2025 | |
| Cardinal Health 200 LLC | $28.99 | 2020 | |
| Sun Pharmaceutical Industries INC. | $28.17 | 2021 | |
| Inari Medical, INC. | $26.15 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Sanofi-Aventis U.S. LLC | $26.11 | 2019-2021 | |
| Cordis US Corp. | $22.67 | 2023 | Mynx Control |
| Bridgebio Pharma, INC. | $15.90 | 2025 | Attruby |
| Janssen Pharmaceuticals, INC | $15.00 | 2019 | |
| Heartflow, INC. | $13.11 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rahul Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.